drugset / Trial / NCT00795587

Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring

NCT00795587

Phase 4 Terminated 3 enrolled University Hospital, Grenoble
RandomizedParallel-groupSingle-blindTreatment

Summary

Will an increase of the dose of mannitol improve the effects on neuromonitoring in patients suffering intracranial hypertension following traumatic brain injury?

Timeline

Start
2008-10
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mannitol Diagnostic / imaging agent 0.4 g/kg
Comparator Mannitol Diagnostic / imaging agent 0.8 g/kg